General MedicationsINJECTIONStandard
EYDENZELT
AFLIBERCEPT-BOAV
Standard Dose
2MG(0.05ML;40MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview EYDENZELT is listed in Drugs@FDA under application 761377 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient AFLIBERCEPT-BOAV Form and strength INJECTABLE;INJECTION - 2MG(0.05ML;40MG/ML) Sponsor CELLTRION INC Submission history Latest submission status date: 2025-10-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview EYDENZELT is listed in Drugs@FDA under application 761377 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient AFLIBERCEPT-BOAV Form and strength INJECTABLE;INJECTION - 2MG(0.05ML;40MG/ML) Sponsor CELLTRION INC Submission history Latest submission status date: 2025-10-02 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.